Tami R. Ellison, M.S. CEO and Founder

Ellison serves as conflu3nce's chief innovator, building the company's R&D strategy and product development plans around her patented and patent-pending methods and processes. She established conflu3nce, ltd in 2016 and Conflu3nce Health AI in 2021 to pursue a health-oriented agenda to support the development of tools capable of advancing early disease detection. She currently holds six issued patents, which focus on image characteristics and figure-ground (depth) properties to help build a bridge between human perception and computer vision towards improving visual attention in both humans and machines. She is currently developing hardware and software tools related to three additional patent-pending technologies designed to transform cognitive biometrics from 20th-century based intelligence assessments of skills to sensitively detecting user-specific changes in cognitive health.

A generalist by design, she brings more than 25 years of industry experience, including: creative/technical marketing communications, business process analysis, de novo conceptualization and visual communications packaging and design across multiple markets, working with a wide range of public/private high tech, biotech, educational and edutainment concerns. An experienced leader and team player, she has conducted numerous training/team building workshops supporting professional development. Her clients have included: ZOME Tools, GeoVideo Networks/Lucent Technologies, Compedia Ltd, Kodak, DNASTAR, and BSSI/Cyvent. She's held numerous leadership positions, including serving as Publishing Manager, Promega Biotech; Executive Director/co-Founder, the YIZKOR Project; VP, Compass Entertainment; and, Lead Change Management Specialist for the Bronner Group developing integrated solutions to enhance customer engagement and meet long/short-term Government workforce development needs. She holds a thesis research Master of Science degree from the Laboratory for Cell, Molecular and Developmental Biology, UIC with extensive research in developmental model systems, expression patterns, and systems-level regulatory control.